Overview
Status
Active
Registry date
2018-07-27
Share capital
33,200.00 PLN
Registered address
Aleja Jana Pawła II 27, 00-867 Warszawa, Poland
Website
Email
Electronic delivery address
AE:PL-74990-63786-GAWBT-19
Financials
Revenue history (in k)
Filing timeliness
3 of 6 financial statements were filed late (the longest delay 77 days for 2021).
- 202520/08/2026
- 202417/07/2025
- 202305/07/2024
- 202216/06/2023
- 202130/09/2022
- 202030/09/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 35.64kMedianUSD 55.24kAverageUSD 2.71m
Net profit
This companyUSD -15.81kMedianUSD -1.27kAverageUSD -91.85k
Operating costs
This companyUSD 48.47kMedianUSD 65.85kAverageUSD 2.66m
Assets
This companyUSD 4.55kMedianUSD 133.19kAverageUSD 3.03m
Industry
Authorized Representatives
Jacek Józef Rosiak – President of the Management Board
Manner of representation
If the management board consists of several persons, two members of the management board acting jointly are authorised to make declarations of will on behalf of the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Dominik Budziakage 48 | 101 | $1,364.13 | 15.2108% |
Jacek Józef Rosiakage 61 | 231 | $3,119.94 | 34.7892% |
Robert Jan Ali Sieradzkiage 62 | 196 | $2,647.22 | 29.5181% |
Jacek Dominik Szkurłatage 62 | 136 | $1,836.84 | 20.4819% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2018-08-08.
43 1020 1097 0000 7002 0316 2484
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Mar 16, 2020 | Aid for research and development projects: experimental development | –– | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Mar 16, 2020 | Aid for research and development projects: industrial research | –– | Dyrektor Narodowego Centrum Badań i Rozwoju | |
| Mar 16, 2020 | Aid for consultancy services for small and medium-sized enterprises | –– | Dyrektor Narodowego Centrum Badań i Rozwoju |
European Funds
| Start | Project | EU co-financing | Programme | |
|---|---|---|---|---|
| 2020-02-01 | Development of an innovative technology for producing atelocollagen from pig tendons for use in implantology and dentistry | $2.4M$2,376,354 | Operational Programme Smart Growth |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Frontline BiosciencesS.A. | $219,186.29 | frontlinebiosciences.com | ||
| AI Corelabsp. z o.o. | $128,365.55 | aicorelab.com | ||
| ModicaP.S.A. | $103,400.72 | modica.bio | ||
| WPD Pharmaceuticalssp. z o.o. | $90,822.78 | wpdpharmaceuticals.com | ||
| WPD PharmaceuticalsS.A. | $87,561.70 | wpdpharmaceuticals.pl | ||
| Stenocoatsp. z o.o. | $36,665.21 | stenocoat.com | ||
| Platforma Badań Genetycznychsp. z o.o. | $28,558.39 | zdrowegeny.pl | ||
| Bioselsp. z o.o. | $19,100.32 | selol.pl | ||
| Omnisepticasp. z o.o. | $3,475.29 | omniseptica.com | ||
| Wavex Energysp. z o.o. | $142.33 | wavexenergy.com |
Change history
| Date | Event | |
|---|---|---|
| 2021-12-31 | Share capital increase (20,000.00 PLN → 33,200.00 PLN) | |
| 2020-05-12 | Address change (Ul. Pelplińska 8b, 01-683, Warszawa → Aleja Jana Pawła Ii 27, 00-867, Warszawa) | |
| 2020-02-27 | Address change (Ul. Prosta 69, 00-838, Warszawa → Ul. Pelplińska 8b, 01-683, Warszawa) | |
| 2019-06-03 | Address change (Ul. Złota 59, 00-120, Warszawa → Ul. Prosta 69, 00-838, Warszawa) | |
| 2018-07-27 | Entered in the register |
FAQ
Last updated: 2026-08-20